• Profile
Close

Changes in fetoplacental doppler indices following intrapartum maternal sildenafil citrate treatment

European Journal of Obstetrics & Gynecology and Reproductive Biology Oct 25, 2020

Turner J, et al. - Researchers examined how intrapartum sildenafil citrate (SC) administration affects fetoplacental blood flow indices. They conducted a subgroup analysis from an earlier phase 2 double blind randomized controlled trial examining the effect of intrapartum SC administration (50 mg orally 8 -hly in labour) vs placebo for the reduction of operative birth for intrapartum fetal compromise. Findings revealed despite non-significant differences in Doppler indices pre- and post- SC treatment, a clear trend towards a reduction in the umbilical artery (UA) pulsatility index (PI), a corresponding increase in the middle cerebral artery (MCA) PI and a rise in post treatment cerebroplacental ratio (CPR) values could be seen. This suggests potential improvement in fetoplacental Dopplers with intrapartum SC treatment. This hypothesis generating study thus yielded results suggesting the possibility to stratify women that would most benefit from this intervention based upon their pre-labour CPR.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay